Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
Go back to Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 201.95 -4.04 (1.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $205.99 | 52 Week High | $333.65 | |||
| Open | $204.08 | 52 Week Low | $223.02 | |||
| Day High | $205.65 | P/E | 25.86 | |||
| Day Low | $201.86 | EPS | $7.81 | |||
| Volume | 415,099 | |||||
| (NASDAQ: IONS) | Delayed: 53.55 -0.84 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.39 | 52 Week High | $62.68 | |||
| Open | $54.47 | 52 Week Low | $19.59 | |||
| Day High | $54.80 | P/E | N/A | |||
| Day Low | $53.52 | EPS | $0.00 | |||
| Volume | 959,836 | |||||
